MX2009002253A - Programa de titulacion para bifeprunox para el tratamiento de esquizofrenia y equipos para usar en el mismo. - Google Patents
Programa de titulacion para bifeprunox para el tratamiento de esquizofrenia y equipos para usar en el mismo.Info
- Publication number
- MX2009002253A MX2009002253A MX2009002253A MX2009002253A MX2009002253A MX 2009002253 A MX2009002253 A MX 2009002253A MX 2009002253 A MX2009002253 A MX 2009002253A MX 2009002253 A MX2009002253 A MX 2009002253A MX 2009002253 A MX2009002253 A MX 2009002253A
- Authority
- MX
- Mexico
- Prior art keywords
- bifeprunox
- kits
- treating schizophrenia
- titration schedule
- titration
- Prior art date
Links
Abstract
La presente invención está dirigida al uso de un compuesto de bifeprunox para un equipo de titulación para un programa de titulación, para facilitar el comienzo del tratamiento de al menos una condición o trastorno del sistema nervioso central mediante la administración de una pluralidad de unidades de dosificación que comprenden un compuesto 7-[4-([1,1'-bifenil]-3-il metil)-1-piperazinil]-2(3H)-benzoxazolona (INN bifeprunox).
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06119936 | 2006-08-31 | ||
EP06120016 | 2006-09-01 | ||
PCT/EP2007/058957 WO2008025780A1 (en) | 2006-08-31 | 2007-08-29 | Titration schedule for bifeprunox for treating schizophrenia and kits for use therein |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2009002253A true MX2009002253A (es) | 2009-06-04 |
Family
ID=40085736
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009002254A MX2009002254A (es) | 2006-08-31 | 2007-08-29 | Dosis de bifeprunox para tratar esquizofrenia. |
MX2009002253A MX2009002253A (es) | 2006-08-31 | 2007-08-29 | Programa de titulacion para bifeprunox para el tratamiento de esquizofrenia y equipos para usar en el mismo. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009002254A MX2009002254A (es) | 2006-08-31 | 2007-08-29 | Dosis de bifeprunox para tratar esquizofrenia. |
Country Status (4)
Country | Link |
---|---|
CN (1) | CN101686978A (es) |
AR (2) | AR063697A1 (es) |
MX (2) | MX2009002254A (es) |
TW (2) | TW200829576A (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115569123B (zh) * | 2022-12-08 | 2023-03-14 | 则正(济南)生物科技有限公司 | 一种富马酸伏诺拉生片剂及其制备方法 |
-
2007
- 2007-08-28 AR ARP070103808 patent/AR063697A1/es not_active Application Discontinuation
- 2007-08-28 TW TW96131862A patent/TW200829576A/zh unknown
- 2007-08-28 AR ARP070103807 patent/AR062561A1/es not_active Application Discontinuation
- 2007-08-28 TW TW96131861A patent/TW200817390A/zh unknown
- 2007-08-29 MX MX2009002254A patent/MX2009002254A/es not_active Application Discontinuation
- 2007-08-29 MX MX2009002253A patent/MX2009002253A/es not_active Application Discontinuation
- 2007-08-29 CN CN200780032312A patent/CN101686978A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
CN101686978A (zh) | 2010-03-31 |
MX2009002254A (es) | 2009-07-24 |
TW200817390A (en) | 2008-04-16 |
AR062561A1 (es) | 2008-11-19 |
TW200829576A (en) | 2008-07-16 |
AR063697A1 (es) | 2009-02-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE50311898D1 (de) | Fredericamycin-derivate als arzneimittel zur tumorbehandlung | |
SG170101A1 (en) | 2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial. | |
BRPI0720551A2 (pt) | composto ou um sal farmaceuticamente aceitável do mesmo, e, uso do mesmo, método para o tratamento de câncer, processos para a preparação de uma composição farmacêutica e de um composto ou de um sal farmaceuticamente aceitável do mesmo | |
UA109878C2 (uk) | Похідні ізохінолінону, фармацевтична композиція на їх основі (варіанти) та спосіб лікування захворювань (варіанти) | |
TW200608979A (en) | Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis | |
MX2008013836A (es) | Derivados de 2-piridona para el tratamiento de enfermedades o condiciones en las cuales es benefica la inhibicion de la actividad de elastasa de neutrofilos. | |
IL195256A0 (en) | Compositions of r(+)and s(-)pramipexole and methods of using the same | |
TW200505483A (en) | New medicament compositions based on anticholinergically-effective compounds and β-mimetics | |
IL160420A0 (en) | Treating or preventing diabetes with cannabidiol | |
GB0318447D0 (en) | Therapeutic agents | |
NZ596579A (en) | Bace inhibitors | |
TW200635582A (en) | Medicaments for the treatment or prevention of fibrotic diseases | |
BRPI0908635B8 (pt) | composto e/ou um sal farmaceuticamente aceitável do mesmo e composição farmacêutica | |
MX2009007345A (es) | Compuestos con (fenil sustituido), con restos de propenal, sus derivados, actividad biologica y uso del mismo. | |
ATE502633T1 (de) | Cyclosporins zur behandlung und vorbeugung von augenerkrankungen | |
TW200716091A (en) | New therapeutic combinations for the treatment or prevention of psychotic disorders | |
SG152237A1 (en) | Pharmaceutical combinations containing benzoxazine for treating respiratory diseases | |
ATE415968T1 (de) | 3,11b-cis-dihydrotetrabanezin zur behandlung von schizophrenie und anderen psychosen | |
TW200602330A (en) | Compounds and compositions as PPAR modulators | |
TW200600505A (en) | Compounds and compositions as ppar modulators | |
EA200701594A1 (ru) | Лакозамид для дополнительной терапии | |
NO20084049L (no) | Forbindelser med forsterket ampa receptor og anvendelse derav i medisin | |
MX2008015775A (es) | Compuestos y composiciones para tratamiento de cancer. | |
MY146920A (en) | Aminothiazole derivatives and their uses as antibacterial agents | |
NO20091243L (no) | Titreringsskjema for bifeprunox for behandling av schizofreni og kits for anvendelse deri |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |